A Christmas day post on Slashdot has sparked a lively debate with comments growing ever longer and more boisterous. At issue: an editorial from Nobel winner Joseph Stiglitz, an economist who rails against the concept of drug patents in the British Medical Journal. The anonymous author of the post claims that "in medicine, patents cost lives."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.